WULF 10-Q Quarterly Report Sept. 30, 2010

WULF 10-Q Quarter ended Sept. 30, 2010

Exhibits

Exhibits

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

TERAWULF INC.

10-Ks and 10-Qs

10-Q	Quarter ended Sept. 30, 2025
10-Q	Quarter ended June 30, 2025
10-Q	Quarter ended March 31, 2025
10-K	Fiscal year ended Dec. 31, 2024
10-Q	Quarter ended Sept. 30, 2024
10-Q	Quarter ended June 30, 2024
10-Q	Quarter ended March 31, 2024
10-K	Fiscal year ended Dec. 31, 2023
10-Q	Quarter ended Sept. 30, 2023
10-Q	Quarter ended June 30, 2023
10-Q	Quarter ended March 31, 2023
10-K	Fiscal year ended Dec. 31, 2022
10-Q	Quarter ended Sept. 30, 2022
10-Q	Quarter ended June 30, 2022
10-Q	Quarter ended March 31, 2022
10-K	Fiscal year ended Dec. 31, 2021
10-Q	Quarter ended Sept. 30, 2021
10-Q	Quarter ended June 30, 2021
10-Q	Quarter ended March 31, 2021
10-K	Fiscal year ended Dec. 31, 2020
10-Q	Quarter ended Sept. 30, 2020
10-Q	Quarter ended June 30, 2020
10-Q	Quarter ended March 31, 2020
10-K	Fiscal year ended Dec. 31, 2019
10-Q	Quarter ended Sept. 30, 2019
10-Q	Quarter ended June 30, 2019
10-Q	Quarter ended March 31, 2019
10-K	Fiscal year ended Dec. 31, 2018
10-Q	Quarter ended Sept. 30, 2018
10-Q	Quarter ended June 30, 2018
10-Q	Quarter ended March 31, 2018
10-K	Fiscal year ended Dec. 31, 2017
10-Q	Quarter ended Sept. 30, 2017
10-Q	Quarter ended June 30, 2017
10-Q	Quarter ended March 31, 2017
10-K	Fiscal year ended Dec. 31, 2016
10-Q	Quarter ended Sept. 30, 2016
10-Q	Quarter ended June 30, 2016
10-Q	Quarter ended March 31, 2016
10-K	Fiscal year ended Dec. 31, 2015
10-Q	Quarter ended Sept. 30, 2015
10-Q	Quarter ended June 30, 2015
10-Q	Quarter ended March 31, 2015
10-K	Fiscal year ended Dec. 31, 2014
10-Q	Quarter ended Sept. 30, 2014
10-Q	Quarter ended June 30, 2014
10-Q	Quarter ended March 31, 2014
10-K	Fiscal year ended Dec. 31, 2013
10-Q	Quarter ended Sept. 30, 2013
10-Q	Quarter ended June 30, 2013
10-Q	Quarter ended March 31, 2013
10-K	Fiscal year ended Dec. 31, 2012
10-Q	Quarter ended Sept. 30, 2012
10-Q	Quarter ended June 30, 2012
10-Q	Quarter ended March 31, 2012
10-K	Fiscal year ended Dec. 31, 2011
10-Q	Quarter ended Sept. 30, 2011
10-Q	Quarter ended June 30, 2011
10-Q	Quarter ended March 31, 2011
10-K	Fiscal year ended Dec. 31, 2010
10-Q	Quarter ended Sept. 30, 2010
10-Q	Quarter ended June 30, 2010
10-Q	Quarter ended March 31, 2010
10-K	Fiscal year ended Dec. 31, 2009

PROXIES

DEF 14A	Filed on Sept. 8, 2025
DEF 14A	Filed on March 26, 2025
DEF 14A	Filed on March 20, 2024
DEF 14A	Filed on March 19, 2024
DEF 14A	Filed on June 21, 2023
DEF 14A	Filed on May 4, 2023
DEF 14A	Filed on Feb. 23, 2023
DEF 14A	Filed on Feb. 13, 2023
DEF 14A	Filed on June 22, 2022
DEF 14A	Filed on May 2, 2022
DEF 14A	Filed on March 23, 2021
DEF 14A	Filed on March 24, 2020
DEF 14A	Filed on March 26, 2019
DEF 14A	Filed on March 23, 2018
DEF 14A	Filed on March 24, 2017
DEF 14A	Filed on March 25, 2016
DEF 14A	Filed on March 25, 2015
DEF 14A	Filed on March 21, 2014
DEF 14A	Filed on March 19, 2013
DEF 14A	Filed on March 20, 2012
DEF 14A	Filed on March 22, 2011
DEF 14A	Filed on March 23, 2010

10-Q 1 c59924e10vq.htm FORM 10-Q e10vq

U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)


þ		Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarterly Period Ended September 30, 2010


o		Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Transition Period From to .

Commission file number 000-25727

IKONICS CORPORATION

(Exact name of registrant as specified in its charter)


Minnesota		41-0730027

(State or other jurisdiction of incorporation or organization)		(I.R.S. employer identification no.)

4832 Grand Avenue
Duluth, Minnesota		55807

(Address of principal executive offices)		(Zip code)

(218) 628-2217

Issuer’s telephone number

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes þ No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files.)

Yes o No o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes o No þ

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer o	Accelerated filer o	Non-accelerated filer o	Smaller reporting company þ
		(Do not check if a smaller reporting company)

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practical date: Common Stock, $.10 par value — 1,973,107 shares outstanding as of November 10, 2010.

IKONICS Corporation

QUARTERLY REPORT ON FORM 10-Q


	PAGE NO.
PART I. FINANCIAL INFORMATION

Item 1. Financial Statements:

Condensed Balance Sheets as of September 30, 2010 (unaudited) and December 31, 2009		3

Condensed Statements of Operations for the Three Months and Nine Months Ended September 30, 2010 and 2009 (unaudited)		4

Condensed Statements of Cash Flows for the Nine Months Ended September 30, 2010 and 2009 (unaudited)		5

Notes to Condensed Financial Statements (unaudited)		6

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		12

Item 3. Quantitative and Qualitative Disclosures about Market Risk		20

Item 4. Controls and Procedures		20

PART II. OTHER INFORMATION		21

SIGNATURES		23

EX-31.1
EX-31.2
EX-32

PART I — FINANCIAL INFORMATION


ITEM 1.		Condensed Financial Statements

IKONICS CORPORATION

CONDENSED BALANCE SHEETS


	September 30		December 31
	2010		2009
	(unaudited)
ASSETS
CURRENT ASSETS:
Cash	$	459,162	$	1,304,586
Short-term investments		2,211,213		802,165
Trade receivables, less allowance of $66,000 in 2010 and $78,000 in 2009		2,187,305		2,015,798
Inventories		2,336,807		2,070,602
Deposits, prepaid expenses and other assets		94,653		61,337
Deferred income taxes		163,000		163,000

Total current assets		7,452,140		6,417,488


PROPERTY, PLANT, AND EQUIPMENT, at cost:
Land and building		5,888,445		5,883,794
Machinery and equipment		2,527,285		2,456,218
Office equipment		748,810		741,895
Vehicles		234,650		241,006

		9,399,190		9,322,913
Less accumulated depreciation		4,322,046		4,088,669

		5,077,144		5,234,244


INTANGIBLE ASSETS, less accumulated amortization of $364,790 in 2010 and $325,576 in 2009		311,829		345,540


	$	12,841,113	$	11,997,272


LIABILITIES AND STOCKHOLDERS’ EQUITY

CURRENT LIABILITIES:
Accounts payable	$	389,826	$	286,610
Accrued compensation		307,484		337,365
Other accrued expenses		128,085		104,408
Income taxes payable		5,988		80,803

Total current liabilities		831,383		809,186


DEFERRED INCOME TAXES		162,000		162,000


Total liabilities		993,383		971,186


STOCKHOLDERS’ EQUITY:
Preferred stock, par value $.10 per share; authorized 250,000 shares; issued none
Common stock, par value $.10 per share; authorized 4,750,000 shares; issued and outstanding 1,972,857 shares in 2010 and 1,967,057 in 2009		197,286		196,706
Additional paid-in capital		2,252,973		2,198,289
Retained earnings		9,397,471		8,631,091

Total stockholders’ equity		11,847,730		11,026,086

	$	12,841,113	$	11,997,272

See notes to condensed financial statements.

IKONICS CORPORATION

CONDENSED STATEMENTS OF OPERATIONS (Unaudited)


	Three Months					Nine Months
	Ended September 30					Ended September 30
	2010		2009			2010		2009
NET SALES	$	4,141,092	$	3,920,663		$	12,073,724	$	11,270,376

COST OF GOODS SOLD		2,474,188		2,337,757			7,093,266		6,825,654


GROSS PROFIT		1,666,904		1,582,906			4,980,458		4,444,722

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES		1,086,577		1,101,610			3,409,441		3,419,030

RESEARCH AND DEVELOPMENT EXPENSES		163,420		164,666			528,622		487,942


INCOME FROM OPERATIONS		416,907		316,630			1,042,395		537,750

GAIN ON SALE OF NON-MARKETABLE EQUITY SECURITIES		—		—			—		29,762

LOSS ON INVESTMENT IN NON- MARKETABLE EQUITY SECURITIES		—		(918,951	)		—		(918,951	)

INTEREST INCOME		6,267		3,070			13,672		5,190


INCOME (LOSS) BEFORE INCOME TAXES		423,174		(599,251	)		1,056,067		(346,249	)

INCOME TAX EXPENSE		135,831		110,134			277,111		163,253


NET INCOME (LOSS)	$	287,343	$	(709,385	)	$	778,956	$	(509,502	)


EARNINGS (LOSS) PER COMMON SHARE:
Basic	$	0.15	$	(0.36	)	$	0.40	$	(0.26	)


Diluted	$	0.15	$	(0.36	)	$	0.39	$	(0.26	)


WEIGHTED AVERAGE COMMON SHARES OUTSTANDING :
Basic		1,974,162		1,967,057			1,971,248		1,975,991


Diluted		1,975,882		1,967,057			1,972,351		1,975,991

See notes to condensed financial statements.

IKONICS CORPORATION

CONDENSED STATEMENTS OF CASH FLOWS (Unaudited)


	Nine Months
	Ended September 30
	2010			2009
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$	778,956		$	(509,502	)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation		304,347			321,759
Amortization		39,214			41,438
Stock based compensation		21,952			17,024
(Gain) loss on sale of equipment and vehicles		(10,766	)		13,582
Loss on intangible asset abandonment		29,918			12,700
Gain on sale of non-marketable equity securities		—			(29,762	)
Loss on investment in non-marketable equity securities		—			918,951
Deferred income taxes		—			35,000
Changes in working capital components:
Trade receivables		(171,507	)		(22,954	)
Inventory		(266,205	)		84,372
Deposits, prepaid expenses and other assets		(33,316	)		98,884
Income tax refund receivable		—			157,873
Accounts payable		103,216			(190,090	)
Accrued expenses		(6,204	)		(92,017	)
Income taxes payable		(74,189	)		—

Net cash provided by operating activities		715,416			857,258


CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant and equipment		(155,681	)		(96,579	)
Proceeds from sale of equipment and vehicles		19,200			18,000
Purchases of intangibles		(35,421	)		(8,472	)
Purchases of short-term investments		(2,216,089	)		(600,000	)
Proceeds on sale of short-term investments		807,041			—
Proceeds from sale of non-marketable equity securities		—			29,762

Net cash used in investing activities		(1,580,950	)		(657,289	)


CASH FLOWS FROM FINANCING ACTIVITIES:
Repurchase of common stock		(15,130	)		(123,844	)
Proceeds from exercise of stock options		35,240			—

Net cash provided by (used in) financing activities		20,110			(123,844	)


NET INCREASE (DECREASE) IN CASH		(845,424	)		76,125

CASH AT BEGINNING OF PERIOD		1,304,586			901,738


CASH AT END OF PERIOD	$	459,162		$	977,863


SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for income taxes, net of refunds received of $81,422 and $119,423, respectively	$	386,299		$	(6,620	)

See notes to condensed financial statements.

IKONICS CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

Basis of Presentation

		The balance sheet of IKONICS Corporation (the “Company”) as of September 30, 2010, and the related statements of operations for the three and nine months ended September 30, 2010 and 2009, and cash flows for the nine months ended September 30, 2010 and 2009, have been prepared without being audited.

		In the opinion of management, these statements reflect all adjustments (consisting of only normal recurring adjustments) necessary to present fairly the financial position of IKONICS Corporation as of September 30, 2010, and the results of operations and cash flows for all periods presented.

		Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America, have been condensed or omitted. Therefore, these statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2009.

		The results of operations for interim periods are not necessarily indicative of results that will be realized for the full fiscal year.

Short Term Investments

The Company’s $2,211,000 of short-term investment is comprised of fully insured certificates of deposit with maturities ranging from six to twelve months and interest rates ranging from 0.2% to 1.9%.

Investments and Fair Value Measurements

		The carrying value of financial instruments, such as cash and cash equivalents, short-term investments, accounts receivable, accounts payable and accrued liabilities approximate their fair value because of their short term nature. We do not hold or issue financial instruments for trading purposes.

		The company’s 2009 investment in non-marketable equity securities was comprised of shares in imaging Technology international (“iTi”) and was carried at cost. Non-marketable equity securities are not adjusted to fair value on a recurring basis; however, they are assessed for an other than temporary decline in fair value. A decline in the fair value of these securities that is determined to be other than temporary will result in a revaluation of its carrying amount to fair value in accordance with FASB ASC 325-20-35 paragraphs 1A and 2. An impairment analysis was conducted in accordance with the provisions within FASB ASC 320-10-35 paragraphs 17 through 35. For the three months ended September 30, 2009, the Company recorded an impairment charge of $918,951 reducing the investment in iTi to $0.

		Management’s assessment of fair value was primarily based on iTi’s recent financial results and iTi’s inability to secure adequate financing or to negotiate the sale of the company to a third party. Consequently, iTi has ceased operations and has been liquidated. In order to increase consistency and comparability in fair value measurements, the FASB Codification establishes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels. These levels, in order of highest priority to lowest priority, are described below:

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities.

Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.

IKONICS CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

Level 3: Unobservable inputs are used when little or no market data is available.

Based on the definition of the levels above and the nature of the inputs as described above, management categorized the methodology used in the valuation of its iTi asset as Level 3.

Inventory

The major components of inventory are as follows:


	Sep 30, 2010			Dec 31, 2009
Raw materials	$	1,414,762		$	1,333,549
Work-in-progress		317,043			277,876
Finished goods		1,557,077			1,351,736
Reduction to LIFO cost		(952,075	)		(892,559	)


Total Inventory	$	2,336,807		$	2,070,602

Earnings Per Common Share (EPS)

		Basic EPS is calculated using net income divided by the weighted average of common shares outstanding. Diluted EPS is similar to Basic EPS except that the weighted average number of common shares outstanding is increased to include the number of additional common shares that would have been outstanding if the potential dilutive common shares, such as those shares subject to options, had been issued.

		Shares used in the calculation of diluted EPS are summarized below:


	Three Months Ended
	Sep 30, 2010		Sep 30, 2009
Weighted average common shares outstanding		1,974,162		1,967,057
Dilutive effect of stock options		1,720		—

Weighted average common and common equivalent shares outstanding		1,975,882		1,967,057


	Nine Months Ended
	Sep 30, 2010		Sep 30, 2009
Weighted average common shares outstanding		1,971,248		1,975,991
Dilutive effect of stock options		1,103		—

Weighted average common and common equivalent shares outstanding		1,972,351		1,975,991

IKONICS CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

Stock-based Compensation

		The Company maintains a stock incentive plan which authorizes the issuance of up to 442,750 shares of common stock. Of those shares, 41,000 were subject to outstanding options and 125,573 were reserved for future grants at September 30, 2010. The plan provides for granting eligible participants stock options or other stock awards, as described by the plan, at option prices ranging from 85% to 110% of fair market value at the date of grant. Options granted expire up to seven years after the date of grant. Such options generally become exercisable over a one to three year period. The plan also includes a clause whereby if any individual shareholder’s ownership percentage increases beyond 20%, all outstanding, unvested awards would become immediately vested.

		The Company charged compensation cost of $7,500 against income for the three months ended September 30, 2010 compared to $6,600 for the three months ended September 30, 2009. For the first nine months of 2010, the Company charged compensation cost of approximately $22,000 against income compared to approximately $17,000 for the same period in 2009. As of September 30, 2010 there was approximately $44,000 of unrecognized compensation cost related to unvested share-based compensation awards granted. That cost is expected to be recognized over the next three years.

		The Company receives a tax deduction for certain stock option exercises during the period in which the options are exercised, generally for the excess of the market price at the time the stock options are exercised over the exercise price of the options, which increased the APIC pool, which is the amount that represents the pool of excess tax benefits available to absorb tax shortages. There were no excess tax benefits recognized during the three or nine month period ending September 30, 2010 and 2009, respectively. The Company’s APIC pool totaled approximately $111,000 at September 30, 2010 and December 31, 2009, respectively.

		Proceeds from the exercise of stock options were $35,000 for the nine months ended September 30, 2010. There were no options exercised during the nine months ended September 30, 2009.

		The fair value of options granted during the nine months ended September 30, 2010 and 2009 were estimated using the Black-Scholes option pricing model with the following assumptions:


	2010			2009
Dividend yield		0	%		0	%
Expected volatility		45.2	%		47.2	%
Expected life of option	Five Years			Five Years
Risk-free interest rate		2.5	%		2.0	%
Fair value of each option on grant date	$	3.08		$	2.10

		There were 4,000 options and 21,750 options granted during the nine months ended September 30, 2010 and 2009, respectively.

		Stock option activity during the nine months ended September 30, 2010 was as follows:

IKONICS CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)


				Weighted
				Average
				Exercise
	Shares			Price
Outstanding at beginning of period		45,500		$	5.91
Granted		4,000			7.39
Exercised		(8,000	)		4.41
Expired and forfeited		(500	)		5.00

Outstanding at September 30, 2010		41,000			6.36

Exercisable at September 30, 2010		20,083			6.90

The aggregate intrinsic value of all options outstanding and for those exercisable at September 30, 2010 was approximately $35,000 and $11,000, respectively.

Segment Information

		The Company’s reportable segments are strategic business units that offer different products and have varied customer bases. There are three reportable segments: Domestic, Export, and IKONICS Imaging. Domestic sells screen printing film, emulsions, and inkjet receptive film to distributors located in the United States and Canada. IKONICS Imaging sells photo resistant film, art supplies, glass, metal medium and related abrasive etching equipment to end user customers located in the United States and Canada. It is also entering the market for etched ceramics, glass and silicon wafers, and is developing and selling proprietary inkjet technology. Export sells primarily the same products as Domestic and IKONICS Imaging to foreign customers. The accounting policies applied to determine the segment information are the same as those described in the summary of significant accounting policies included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2009.

		Management evaluates the performance of each segment based on the components of divisional income, and with the exception of trade receivables, does not allocate assets and liabilities to segments. Financial information with respect to the reportable segments follows:

		For the three months ended September 30, 2010:


					IKONICS
	Domestic		Export		Imaging		Other			Total
Net sales	$	1,671,062	$	1,413,108	$	1,056,922	$	—		$	4,141,092
Cost of goods sold		888,023		1,021,437		564,728		—			2,474,188

Gross profit		783,039		391,671		492,194		—			1,666,904
Selling, general and administrative*		231,668		119,113		280,277		455,519			1,086,577
Research and development*		—		—		—		163,420			163,420


Income from operations	$	551,371	$	272,558	$	211,917	$	(618,939	)	$	416,907

IKONICS CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

For the three months ended September 30, 2009:


					IKONICS
	Domestic		Export		Imaging		Other			Total
Net sales	$	1,702,631	$	1,329,464	$	888,568	$	—		$	3,920,663
Cost of goods sold		880,967		955,366		501,424		—			2,337,757

Gross profit		821,664		374,098		387,144		—			1,582,906
Selling, general and administrative*		211,180		131,183		245,930		513,317			1,101,610
Research and development*		—		—		—		164,666			164,666


Income from operations	$	610,484	$	242,915	$	141,214	$	(677,983	)	$	316,630

For the nine months ended September 30, 2010:


					IKONICS
	Domestic		Export		Imaging		Other			Total
Net sales	$	4,962,625	$	4,042,887	$	3,068,212	$	—		$	12,073,724
Cost of goods sold		2,589,379		2,827,152		1,676,735		—			7,093,266

Gross profit		2,373,246		1,215,735		1,391,477		—			4,980,458
Selling, general and administrative*		718,275		444,767		848,344		1,398,055			3,409,441
Research and development*		—		—		—		528,622			528,622


Income from operations	$	1,654,971	$	770,968	$	543,133	$	(1,926,677	)	$	1,042,395

For the nine months ended September 30, 2009:


					IKONICS
	Domestic		Export		Imaging		Other			Total
Net sales	$	5,055,963	$	3,452,937	$	2,761,476	$	—		$	11,270,376
Cost of goods sold		2,676,991		2,598,502		1,550,161		—			6,825,654

Gross profit		2,378,972		854,435		1,211,315		—			4,444,722
Selling, general and administrative*		716,708		386,805		830,457		1,485,060			3,419,030
Research and development*		—		—		—		487,942			487,942


Income from operations	$	1,662,264	$	467,630	$	380,858	$	(1,973,002	)	$	537,750


*		The Company does not allocate all general and administrative expenses or any research and development expenses to its operating segments for internal reporting.

Trade receivables by segment as of September 30, 2010 and December 31, 2009 were as follows:


	Sep 30, 2010			Dec 31, 2009
Domestic	$	913,311		$	976,967
Export		901,009			740,547
IKONICS Imaging		403,016			331,117
Other, net of allowances		(30,031	)		(32,833	)


Total	$	2,187,305		$	2,015,798

IKONICS CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

Sale of Non-Marketable Equity Securities

The Company received and realized a gain of $29,762 during the first nine months of 2009 related to the 2007 sale of its equity investment in Apprise Technologies, Inc.

Income Taxes

		The Company reports a liability for unrecognized tax benefit taken or expected to be taken when they are uncertain. During the first nine months of 2010 and 2009, the statute of limitations for the relevant taxing authority to examine and challenge the tax position for an open year expired, resulting in decreases in income tax expense of $27,000 for the first nine months of 2010 and $21,000 for the first nine months of 2009. As of September 30, 2010, there was no liability for unrecognized tax benefits compared to a liability of $27,000 as of September 30, 2009. The liability for unrecognized tax benefits was previously included in other accrued expenses.

		The Company is subject to taxation in the United States and various states. The material jurisdictions that are subject to examination by tax authorities primarily include Minnesota and the United States, for tax years 2007, 2008, and 2009.

		It has been the Company’s policy to recognize interest and penalties related to uncertain tax positions in income tax expense. The Company had accrued approximately $8,000 of interest related to uncertain tax positions at December 31, 2009, all of which was reversed and included in income tax benefit on the Statement of Operations for the first nine months of 2010. The unrecognized tax benefits at September 30, 2009 related to taxation of foreign export sales.

IKONICS CORPORATION

The information presented below in Management’s Discussion and Analysis of Financial Condition and Results of Operations contains forward-looking statements within the meaning of the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended. Such statements are subject to risks and uncertainties, including those discussed under “Factors that May Affect Future Results” below, that could cause actual results to differ materially from those projected. Because actual results may differ, readers are cautioned not to place undue reliance on these forward-looking statements. Certain forward-looking statements are indicated by italics.


ITEM 2.		Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following management’s discussion and analysis focuses on those factors that had a material effect on the Company’s financial results of operations during the third quarter of 2010, the nine months ended September 30, 2010 and the same periods of 2009. It should be read in connection with the Company’s unaudited financial statements and notes thereto included in this Form 10-Q and the Company’s audited financial statements, including related notes, and Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in the Company’s 2009 Annual Report on Form 10-K.

Factors that May Affect Future Results

	•		The Company’s expectation that its effective tax rate will return to 35% to 36% of pretax income for the remainder of 2010 compared to the tax expense recorded in the first nine months of 2010 —The effective tax rate for the final three months of 2010 may be affected by changes in federal and state tax law, unanticipated changes in the Company’s financial position or the Company’s operating activities and/or management decisions could increase or decrease its effective tax rate.

	•		The Company’s belief that the quality of its receivables is high and that strong internal controls are in place to maintain proper collections —This belief may be impacted by domestic economic conditions, by economic, political, regulatory or social conditions in foreign markets, or by the failure of the Company to properly implement or maintain internal controls.

	•		The belief that the Company’s current financial resources, cash generated from operations and the Company’s capacity for debt and/or equity financing will be sufficient to fund current and anticipated business operations and capital expenditures. The belief that the Company’s low debt levels and available line of credit make it unlikely that a decrease in product demand would impair the Company’s ability to fund operations —Changes in anticipated operating results, credit availability, equity market conditions or the Company’s debt levels may further enhance or inhibit the Company’s ability to maintain or raise appropriate levels of cash.

	•		The Company’s expectations as to the level and use of planned capital expenditures and that capital expenditures will be funded with cash on hand and cash generated from operating activities —This expectation may be affected by changes in the Company’s anticipated capital expenditure requirements resulting from unforeseen required maintenance, repairs, or capital asset additions. The funding of planned or unforeseen expenditures may also be affected by changes in anticipated operating results resulting from decreased sales, lack of acceptance of new products or increased operating expenses or by other unexpected events affecting the Company’s financial position.

	•		The Company’s belief that its vulnerability to foreign currency fluctuations and general economic conditions in foreign countries is not significant —This belief may be impacted by economic, political and social conditions in foreign markets, changes in regulatory and competitive conditions, a change in the amount or geographic focus of the Company’s international sales, or changes in purchase or sales terms.

	•		The Company’s plans to continue to invest in research and development efforts, expedite internal product development and invest in technological alliances, as well as the expected focus and results of such investments —These plans and expectations may be impacted by general market conditions, unanticipated changes in expenses or sales, delays in the development of new products, technological advances, the ability to find suitable and willing technology partners or other changes in competitive or market conditions.

	•		The Company’s efforts to grow its international business —These efforts may be impacted by economic, political and social conditions in current and anticipated foreign markets, regulatory conditions in such markets, unanticipated changes in expenses or sales, changes in competitive conditions or other barriers to entry or expansion.

	•		The Company’s belief as to future activities that may be undertaken to expand the Company’s business —Actual activities undertaken may be impacted by general market conditions, competitive conditions in the Company’s industry, unanticipated changes in the Company’s financial position, lack of acceptance of new products or the inability to identify attractive acquisition targets or other business opportunities.

Critical Accounting Estimates

The Company prepares its financial statements in conformity with accounting principles generally accepted in the United States of America. Therefore, the Company is required to make certain estimates, judgments and assumptions that the Company believes are reasonable based upon the information available. These estimates and assumptions affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. The accounting estimates, which IKONICS believes are the most critical to aid in fully understanding and evaluating its reported financial results, include the following:

Accounts Receivable. The Company performs ongoing credit evaluations of its customers and adjusts credit limits based upon payment history and the customer’s current credit worthiness, as determined by review of the current credit information. The Company continuously monitors collections and payments from its customers and maintains a provision for estimated credit losses based upon historical experience and any specific customer collection issues that have been identified. While such credit losses have historically been within expectations and the provisions established, the Company cannot guarantee that it will continue to experience the same collection history that has occurred in the past. The general payment terms are net 30-45 days for domestic customers and net 30-90 days for foreign customers. A small percentage of the accounts receivable balance is denominated in a foreign currency with no concentration in any given country. At the end of each reporting period, the Company analyzes the receivable balance for customers paying in a foreign currency. These balances are adjusted to each quarter or year spot rate in accordance with guidance related to foreign currency matters.

Inventories. Inventories are valued at the lower of cost or market value using the last in, first out (LIFO) method. The Company monitors its inventory for obsolescence and records reductions in cost when required.

Income Taxes. At September 30, 2010, the Company had net current deferred tax assets of $163,000 and net noncurrent deferred tax liabilities of $162,000. The deferred tax assets and liabilities result primarily from temporary differences in property and equipment, accrued expenses, and inventory reserves. In connection with the recording of a $919,000 impairment charge in 2009 related to an investment in a non-marketable equity security, the Company has recorded a deferred tax asset and corresponding full valuation allowance in the amount of $331,000 as of September 30, 2010 and December 31, 2009 as it is more likely that this asset will not be realized. The deferred tax asset related to the capital loss can be carried back three years and carried forward five years and must be offset by a capital gain. The Company has determined that it is more likely than not that the remaining deferred tax assets will be realized and that an additional valuation allowance for such assets is not currently required. The Company reports a liability for unrecognized tax benefits taken or expected to be taken when they are uncertain. At

December 31, 2009 the Company had recorded a liability of $27,000 related to an uncertain tax position which was eliminated during the nine months ended September 30, 2010.

Investments and Fair Value Measurements . The carrying value of financial instruments, such as cash and cash equivalents, short-term investments, accounts receivable, accounts payable and accrued liabilities approximate their fair value because of their short term nature. We do not hold or issue financial instruments for trading purposes.

The Company’s 2009 investment in non-marketable securities was comprised of shares in iTi and was previously carried at cost. Non-marketable securities are not adjusted to fair value on a recurring basis; however, they are assessed for an other than temporary decline in fair value. A decline in the fair value for these securities occurred in the third quarter of 2009 and was determined to be other than temporary, resulting in a revaluation of its carrying amount to fair value in accordance with FASB ASC 325-20-35 paragraphs 1A and 2. The impairment analysis was conducted in accordance with the provisions within FASB ASC 320-10-35 paragraphs 17 through 35. For the three months ended September 30, 2009, the Company recorded an impairment charge of $918,951, reducing the investment in iTi to $0. The Company did not incur an impairment charge for the nine months ended September 30, 2010.

Management’s assessment of iTi’s fair value was primarily based on its recent financial results and iTi’s inability to secure adequate financing, or to negotiate the sale of the company to a third party. Consequently, iTi has ceased operations and is currently evaluating its options including liquidation. In order to increase consistency and comparability in fair value measurements, the FASB Codification establishes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels. These levels, in order of highest priority to lowest priority, are described below:

		Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities.

		Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.

		Level 3: Unobservable inputs are used when little or no market data is available.

Based on the definition of the levels above and the nature of the inputs as described above, management has categorized the methodology used in the valuation of its iTi asset as Level 3.

Revenue Recognition. The Company recognizes revenue on sales of products when title passes which can occur at the time of shipment or when the goods arrive at the customer location depending on the agreement with the customer. The Company sells its products to both distributors and end-users. Sales to distributors and end-users are recorded based upon the criteria governed by the sales, delivery, and payment terms stated on the invoices from the Company to the purchaser. In addition to transfer of title / risk of loss, all revenue is recorded in accordance with the criteria outlined within the provisions regarding revenue recognition including:

	(a)		persuasive evidence of an arrangement (principally in the form of customer sales orders and the Company’s sales invoices)

	(b)		delivery and performance (evidenced by proof of delivery, e.g. the shipment of film and substrates with bill of lading used for proof of delivery for FOB shipping point terms, and the carrier booking confirmation report used for FOB destination terms). Once the finished product is shipped and physically delivered under the terms of the invoice and sales order, the Company has no additional performance or service obligations to complete

	(c)		a fixed and determinable sales price (the Company’s pricing is established and is not based on variable terms, as evidenced in either the Company’s invoices or the limited number of distribution agreements; the Company rarely grants extended payment terms and has no history of concessions)

	(d)		a reasonable likelihood of payment (the Company’s terms are standard, and the Company does not have a substantial history of customer defaults or non-payment)

Sales are reported on a net basis by deducting credits, estimated normal returns and discounts. The Company’s return policy does not vary by geography. The Company is not under a warranty obligation and the customer has no rotation or price protection rights. Freight billed to customers is included in sales. Shipping costs are included in cost of goods sold.

Results of Operations

Quarter Ended September 30, 2010 Compared to Quarter Ended September 30, 2009

Sales. The Company realized a 5.6% sales increase during the third quarter of 2010 with sales of $4.1 million, compared to $3.9 million in sales during the same period in 2009. IKONICS Imaging sales for the third quarter of 2010 were up 18.9% versus the third quarter of 2009 due to strong film sales including increased shipments related the Company’s Digital Texturing initiative. Export 2010 third quarter sales also increased by 6.3% over the same period in 2009 as the Company realized higher sales to Latin America. Domestic sales dropped by 1.9% in third quarter of 2010 due to lower film and emulsion sales.

Gross Profit . Gross profit was $1.7 million, or 40.3% of sales, in the third quarter of 2010 compared to $1.6 million, or 40.4% of sales, for the same period in 2009. IKONICS Imaging gross profit percentage increased to 46.6% during the third quarter of 2010 compared to 43.6% in the third quarter of 2009 due to increased volume and an improved sales mix. A less favorable sales mix negatively affected both Export and Domestic’s 2010 third quarter gross profit percentage. Export’s third quarter gross profit percentage decreased from 28.1% in 2009 to 27.7% in 2010 while Domestic’s third quarter gross profit percentage decreased from 48.3% in 2009 to 46.9% in 2010.

Selling, General and Administrative Expenses . Selling, general and administrative expenses of $1.1 million, or 26.2% of sales, in the third quarter of 2010 were comparable to the 2009 third quarter selling general and administrative expenses of $1.1 million, or 28.1% of sales.

Research and Development Expenses . Research and development expenses during the third quarter of 2010 were $163,000, or 3.9% of sales, versus $165,000, or 4.2% of sales, for the same period in 2009. The decrease is due to lower costs related to research and development production runs.

Loss on Investment in Non-marketable Equity Securities. The Company’s 2009 investment in non-marketable securities was comprised of shares in iTi and was previously carried at cost. Non-marketable securities are not adjusted to fair value on a recurring basis; however, they are assessed for an other than temporary decline in fair value. A decline in the market value for these securities that is determined to be other than temporary results in a revaluation of its carrying amount to fair value. An impairment analysis was conducted in accordance with applicable accounting standards during the third quarter of 2009, and the Company recorded an impairment charge of $918,951 for the quarter, which represents a full write-off of the Company’s investment in iTi to $0. The Company did not have any non-marketable equity securities as of September 30, 2010 and did not have any loss on any investment in such securities during the third quarter of 2010.

Interest Income. The Company earned $6,300 of interest income in the third quarter of 2010 compared to $3,000 of interest income in the third quarter of 2009. The interest earned in third quarter of 2010 and 2009 is related to interest received from the Company’s short-term investments, which consisted of fully insured certificates of deposit with maturities ranging from six to twelve months.

Income Taxes. For the third quarter of 2010, the Company realized income tax expense of $136,000, or an effective rate of 32.1% versus a $110,000 tax expense for the third quarter of 2009. The 2010 income tax provision differs from the expected tax expense primarily due to the benefits of the domestic manufacturing deduction, and state credits for research and development. In 2009 the Company did not receive a tax benefit from the $919,000 loss on investment in non-marketable equity securities since the Company recorded a full valuation allowance

against the deferred tax asset resulting from the loss on the capital asset impairment charge, as it is currently more likely that the deferred tax asset will not be realized.

Nine Months Ended September 30, 2010 Compared to the Nine Months Ended September 30, 2009

Sales. The Company’s sales increased 7.1% during the first nine months of 2010 to $12.1 million versus sales of $11.3 million during the first nine months of 2009. Strong sales in Europe and Latin America drove a 17.1% Export sales increase for the first nine months of 2010 compared to the same period in 2009. IKONICS Imaging also realized an 11.1% sales increase over 2009 from improved film shipments to the digital texturing and photo resistant film markets. Partially offsetting these sales increases, Domestic shipments decreased 1.8% during the first nine months of 2010 over the same period in 2009 due to lower private label film shipments.

Gross Profit . Gross Profit for the first nine months of 2010 was $5.0 million, or 41.3% of sales compared to $4.4 million, or 39.4% of sales, for the same period in 2009. Export gross profit percentage increased to 30.1% during the first nine months of 2010 compared to 24.7% for the same period in 2009 due to higher volumes and an improved sales mix. Improved volumes and sales mix also accounted for IKONICS Imaging gross profit percentage increase from 43.9% in the first nine months of 2009 to 45.4% in the first nine months of 2010. Domestic gross profit percentage improved slightly from 47.1% in the 2009 period to 47.8% in the 2010 period.

Selling, General and Administrative Expenses . Selling, general and administrative expenses of $3.4 million, or 28.2% of sales, in the first nine months of 2010 were comparable to selling general and administrative expenses for the same period in 2009 of $3.4 million, or 30.3% of sales.

Research and Development Expenses . Research and development expenses during the first nine months of 2010 were $529,000, or 4.4% of sales, versus $488,000, or 4.3% of sales, for the same period in 2009. The increase is related to the $30,000 abandonment of patent applications The Company records patent application costs as an asset and amortizes those costs upon successful completion of the application process or expenses those costs when an application is abandoned. Additionally, the Company realized increased costs related to research and development production runs.

Gain on Sale of Non-Marketable Equity Securities. The Company realized a gain of $29,800 during the first nine months of 2009 on the sale of its investment in the common and preferred stock of Apprise Technologies, Inc. The original sale took place during 2007. The final $29,800 received in the first nine months of 2009 was related to a portion of the original sales price that was placed in escrow at the time of the sale for indemnification obligations as part of the agreement between Apprise and its purchaser. The Company did not have any non-marketable equity securities as of September 30, 2010 and did not have any gain on any such securities during the first nine months of 2010.

Loss on Investment in Non-Marketable Equity Securities . The company’s 2009 investment in non-marketable securities was comprised of shares in iTi and was previously carried at cost. Non-marketable securities are not adjusted to fair value on a recurring basis; however, they are assessed for an other than temporary decline in fair value. A decline in the market value for these securities that is determined to be other than temporary results in a revaluation of its carrying amount to fair value. An impairment analysis was conducted in accordance with applicable accounting standards during the third quarter of 2009, and the Company recorded an impairment charge of $918,951, which represents a full write-off of the Company’s investment in iTi to $0. The Company did not have any loss on any investment in non-marketable equity securities during the first nine months of 2010.

Interest Income. The Company earned $13,700 of interest income during the first nine months of 2010 compared to $5,200 of interest income for the same period in 2009. The interest earned in first nine months of 2010 and 2009 is related to interest received from the Company’s short-term investments, which consisted of fully insured certificates of deposit with maturities ranging from six to twelve months.

Income Taxes . During the first nine months of 2010, the Company realized an income tax expense of $277,000, or an effective rate of 26.2%, compared to income tax expense of $163,000 for the same period in 2009. The effective tax rate for the first nine months of 2010 and 2009 was impacted by derecognizing a liability for unrecognized tax benefits relating to a tax year where the statute of limitations expired during the first nine months. A $27,000 liability was derecognized in

the first nine months of 2010 while a $21,000 liability was derecognized in the first nine months of 2009. During the first nine months of 2010, the Company also recorded an out-of-period tax benefit adjustment of $15,000 relating to December 31, 2009 estimates for tax credits as well as the receipt of interest of approximately $13,000 related to Minnesota state income tax returns. The Company expects that for the remainder of 2010, the Company will record the provision for income taxes at an effective tax rate of 35% to 36%, as it recognizes benefits from the domestic manufacturing deduction, research and development credits, and state income taxes. In 2009 the Company did not receive a tax benefit from the $919,000 loss on investment in non-marketable equity securities since the Company recorded a full valuation allowance against the deferred tax asset resulting from the loss on the capital asset impairment charge, as it is currently more likely that the deferred tax asset will not be realized.

Liquidity and Capital Resources

The Company has financed its operations principally with funds generated from operations. These funds have been sufficient to cover the Company’s normal operating expenditures, annual capital requirements, and research and development expenditures.

Cash on hand was $459,000 and $978,000 at September 30, 2010 and 2009, respectively. The Company generated $715,000 in cash from operating activities during the nine months ended September 30, 2010, compared to generating $857,000 of cash from operating activities during the same period in 2009. Cash provided by operating activities is primarily the result of net income adjusted for non-cash depreciation, amortization, and certain changes in working capital components discussed in the following paragraph.

During the first nine months of 2010, trade receivables increased by $172,000. The increase in receivables was driven by higher sales volumes specifically to export customers who typically have longer credit terms. The Company believes that the quality of its receivables is high and that strong internal controls are in place to maintain proper collections. Inventory levels increased $266,000 due to inventory purchases to support its Digital Texturing program. Deposits, prepaid expenses and other assets increased $33,000 resulting from the prepayment of insurance premiums. Accounts payable increased $103,000 due to of the timing of payments to and purchases from vendors. Accrued liabilities increased $6,000 and income taxes payable decreased $74,000 reflecting 2010 estimated tax payments.

During the first nine months of 2010, investing activities used $1,581,000. The Company invested $2,215,000 in fully insured certificates of deposits with four $200,000 certificates of deposit maturing during the first nine months of 2010. Purchases of property and equipment totaled $155,000, mainly for three vehicles and equipment purchases. The Company received $19,000 from vehicle sales during the period. Also during the first nine months of 2010, the Company incurred $35,000 in patent application costs that the Company records as an asset and amortizes upon successful completion of the application process.

During the first nine months of 2009, investing activities used $657,000. The Company invested $600,000 in fully insured certificates on deposits. Purchases of property and equipment were $97,000, mainly for new equipment to support the Company’s new business initiatives and research activities. Also during the first nine months of 2009, the Company incurred $8,000 in patent application costs that the Company records as an asset and amortizes upon successful completion of the application process. The Company received proceeds of approximately $30,000 in the first nine months of 2009 on the 2007 sale of its investment in the common and preferred stock of Apprise Technologies, Inc. and $18,000 on the sale of equipment.

During the first nine months of 2010 the Company received $20,000 from financing activities. The Company received $35,000 from the issuance of 8,000 shares of common stock from the exercise of stock options and the Company repurchased 2,200 shares of it own stock for $15,000 The Company used $124,000 in financing activities during the first nine months of 2009 to repurchase 26,926 shares of its own stock.

A bank line of credit exists providing for borrowings of up to $1,250,000. Outstanding debt under this line of credit is collateralized by trade receivables and inventory and bears interest at 2.5 percentage points over the 30-day LIBOR rate. The Company did not utilize this line of credit during the first nine months of 2010 and there

were no borrowings outstanding as of September 30, 2010. The line of credit was also not utilized during first nine months of 2009, and there were no borrowings outstanding under this line as of September 30, 2009. The line of credit expired on October 30, 2010, however, a new $1,250,000 line of credit which expires on October 30, 2011 was established. Outstanding debt under this line of credit is collateralized by trade receivables and inventory and bears interest at 2.5 percentage points over the 30-day LIBOR rate.

The Company believes that current financial resources, its line of credit, cash generated from operations and the Company’s capacity for debt and/or equity financing will be sufficient to fund current and anticipated business operations. The Company also believes that its low debt levels and available line of credit make it unlikely that a decrease in demand for the Company’s products would impair the Company’s ability to fund operations.

Capital Expenditures

Through the first nine months of 2010, the Company had $156,000 in capital expenditures. These capital expenditures were mainly for three vehicles for sales persons and equipment. The Company plans for other capital expenditures during 2010 to include ongoing manufacturing equipment upgrades. Capital expenditures are expected to be approximately $50,000 for the last three months of 2010 and will be funded with cash generated from operating activities.

International Activity

The Company markets its products to numerous countries in North America, Europe, Latin America, Asia and other parts of the world. Export sales were approximately 34% of total sales during the first nine months of 2010 compared to 31% of sales during the same period in 2009. Higher volumes in Europe and Latin American positively impacted 2010 sales volumes for the first nine months. Fluctuations of certain foreign currencies have not significantly impacted the Company’s operations because the Company’s foreign sales are not concentrated in any one region of the world. The Company believes its vulnerability to uncertainties due to foreign currency fluctuations and general economic conditions in foreign countries is not significant.

The Company’s foreign transactions are primarily negotiated, invoiced and paid in U.S. dollars, while a portion is transacted in Euros. IKONICS has not implemented an economic hedging strategy to reduce the risk of foreign currency translation exposures, which management does not believe to be significant based on the scope and geographic diversity of the Company’s foreign operations as of September 30, 2010. Furthermore, the impact of foreign exchange on the Company’s balance sheet and operating results was not material in either 2010 or 2009.

Future Outlook

IKONICS has spent on average over 4% of its sales dollars for the past few years in research and development and has made capital expenditures related to its Digital texturing program. The Company plans to maintain its efforts in this area and expedite internal product development as well as form technological alliances with outside experts to commercialize new product opportunities.

The Company made substantial progress on its new business initiatives during the first nine months of 2010. Photomachining and sound deadening are in commercial operation and supplying product to major electronics, defense and aerospace customers. Two Digital Texturing printers are placed at a beta site; and they are performing to the Company’s expectations and are generating sales of related consumables. The Digital Texturing program was negatively impacted by the 2009 business failure of the Company’s printer supplier, imaging Technology international. However, the Company has made arrangements with two printer manufacturers that the Company believes are both financially strong and technically adept for sourcing future machines. The Company is producing and selling custom substrates for various inkjet applications and is currently developing, under a research contract, a proprietary film product for a major customer.

Other future activities undertaken to expand the Company’s business may include acquisitions, building improvements, equipment additions, new product development and marketing opportunities. In addition to its traditional emphasis on domestic markets, the Company will continue efforts to grow its business internationally by attempting to develop new markets and expanding market share where it has already established a presence.

Recent Accounting Pronouncements

The Company does not expect that the adoption of other recent accounting pronouncements will have a material impact on its financial statements.

Off Balance Sheet Arrangements

The Company has no off-balance sheet arrangements.


ITEM 3.		Quantitative and Qualitative Disclosures about Market Risk

Not applicable


ITEM 4.		Controls and Procedures

As of the end of the period covered by this report, the Company conducted an evaluation, under the supervision and with the participation of the principal executive officer and principal financial officer, of the Company’s disclosure control and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)). Based on this evaluation, the principal executive officer and principal financial officer concluded that the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and (ii) accumulated and communicated to the Company’s management, including its principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

There was no change in the Company’s internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and Rule 15d-15(d) of the Exchange Act that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION


ITEM 1.		Legal Proceedings

None


ITEM 1A.		Risk Factors

Not applicable


ITEM 2.		Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities(1)

(c) Total Number of

Shares Purchased as

(d) Maximum Number of

(a) Total Number

Part of Publicly

Shares that May

(b) Average Price

Announced Plans

Yet Be Purchased Under

Shares Purchased

Paid per Share

or Programs

The Plans or Programs

July 1, 2010 through July 31, 2010

—

n/a

—

35,231

August 1, 2010 through August 31, 2010

2,200

6.88

2,200

33,031

September 1, 2010 through September 30, 2010

—

n/a

—

33,031


(1)		In prior years, the Company’s board of directors had authorized the repurchase of 150,000 shares of common stock. In August 2008, the Company’s Board of Directors approved the repurchase of an additional 100,000 shares of common stock bringing the total shares eligible for repurchase to 250,000. A total of 206,370 shares have been repurchased under this program including 2,200 shares repurchased during the third quarter of 2010. The plan allows for an additional 33,031 shares to be repurchased.


ITEM 3.		Defaults upon Senior Securities

Not applicable


ITEM 4.		[Removed and Reserved]


ITEM 5.		Other Information

None


ITEM 6.		Exhibits

The following exhibits are filed as part of this Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2010:


Exhibit		Description
3.1		Restated Articles of Incorporation of Company, as amended. ¹

3.2		By-Laws of the Company, as amended. ²

31.1		Rule 13a-14(a)/15d-14(a) Certifications of CEO

31.2		Rule 13a-14(a)/15d-14(a) Certifications of CFO

32		Section 1350 Certifications


¹		Incorporated by reference to the like numbered Exhibit to the Company’s Registration Statement on Form 10-SB (File No. 000-25727).

²		Incorporated by reference to the like numbered Exhibit to the Company’s Current Report on Form 8-K filed with the Commission on February 22, 2007 (File No. 000-25727).

Copies of Exhibits will be furnished upon request and payment of the Company’s reasonable expenses in furnishing the Exhibits.

IKONICS CORPORATION

SIGNATURES

In accordance with the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

INDEX TO EXHIBITS


Exhibit	Description	Page
3.1	Restated Articles of Incorporation of Company, as amended	Incorporated by reference
3.2	By-Laws of the Company, as amended.	Incorporated by reference
31.1	Rule 13a-14(a)/15d-14(a) Certifications of CEO.	Filed Electronically
31.2	Rule 13a-14(a)/15d-14(a) Certifications of CFO.	Filed Electronically
32	Section 1350 Certifications.	Filed Electronically

TABLE OF CONTENTS

Part I Financial Information Item 1. Condensed Financial Statements Item 2. Management S Discussion and Analysis Of Financial Condition and Results Of Operations Item 3. Quantitative and Qualitative Disclosures About Market Risk Item 4. Controls and Procedures Part II. Other Information Item 1. Legal Proceedings Item 1A. Risk Factors Item 2. Unregistered Sales Of Equity Securities and Use Of Proceeds Item 3. Defaults Upon Senior Securities Item 4. [removed and Reserved]Item 5. Other Information Item 6. Exhibits

EX-31.1 EX-31.2 EX-32

IKONICS CORPORATION

DATE: November 12, 2010

/s/ Jon Gerlach

Jon Gerlach,

Chief Financial Officer, and

Vice President of Finance